Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PuraMed BioScience has commenced a clinical trial of its non-prescription migraine treatment, LipiGesic M in children and adolescents.
Subscribe to our email newsletter
LipiGesic M is a homeopathic product comprising feverfew and ginger, formulated for acute migraine headache relief.
Feverfew (Pyrethrum Parthenium), the active ingredient in LipiGesic M, is an herb that is thought to have a beneficial effect on migraine, menstrual and other headaches.
LipiGesic M utilises a sublingual delivery method to speed absorption and increase the amount of active ingredient absorbed, delivering relief in minutes.
PuraMed BioScience CEO Russ Mitchell said due to the high efficacy rate and low side effect profile, LipiGesic M may be the best option for migraine relief amongst adults, as well as children.
The multi-site double blind placebo controlled study will enroll children aged 6-11 as well as adolescents aged 12-17 at key centers across the country.